Clinical Trial Update: Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intranasal insulin for depressive symptoms in adults with major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED